Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 13.037\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) c1ccc(-c2cn3nc4c(nc3n2)CCCC4)cc1
b.) Cc1nnc(NC(=O)CSc2nnc(Cc3cccn3C)n2C)s1
c.) CCOC(=O)CSc1ncc(OC)c(=O)[nH]1
d.) CC(C)n1nnnc1SCC(=O)NC1CCCC1
Answer: d. CC(C)n1nnnc1SCC(=O)NC1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)n1nnnc1SCC(=O)NC1CCCC1
CC(C)n1nnnc1SCC(=O)NC1CCCC1
N-cyclopentyl-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide